Ocular Therapeutix’s experimental eye drug showed superiority to Regeneron’s Eylea in a key late-stage trial, but its modest advantage and higher rates of certain side…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/ocular-therapeutixs-eye-drug-superior-regenerons-eylea-late-2026a10004z0?src=rss
Author :
Publish date : 2026-02-17 12:08:00
Copyright for syndicated content belongs to the linked Source.